JP2013507907A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507907A5 JP2013507907A5 JP2012533696A JP2012533696A JP2013507907A5 JP 2013507907 A5 JP2013507907 A5 JP 2013507907A5 JP 2012533696 A JP2012533696 A JP 2012533696A JP 2012533696 A JP2012533696 A JP 2012533696A JP 2013507907 A5 JP2013507907 A5 JP 2013507907A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- domain
- vector
- polynucleotide sequence
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020001507 fusion proteins Proteins 0.000 claims 23
- 102000037865 fusion proteins Human genes 0.000 claims 23
- 239000013598 vector Substances 0.000 claims 17
- 108091033319 polynucleotide Proteins 0.000 claims 16
- 102000040430 polynucleotide Human genes 0.000 claims 16
- 239000002157 polynucleotide Substances 0.000 claims 16
- 239000012634 fragment Substances 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 9
- 230000002163 immunogen Effects 0.000 claims 7
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 150000001413 amino acids Chemical class 0.000 claims 4
- 239000000427 antigen Substances 0.000 claims 4
- 102000036639 antigens Human genes 0.000 claims 4
- 108091007433 antigens Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 3
- 125000003729 nucleotide group Chemical group 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 101710159767 C4b-binding protein alpha chain Proteins 0.000 claims 2
- 102100037084 C4b-binding protein alpha chain Human genes 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 2
- 206010062207 Mycobacterial infection Diseases 0.000 claims 2
- 101100377720 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) fbpA gene Proteins 0.000 claims 2
- 101100377732 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) fbpB gene Proteins 0.000 claims 2
- 101100489774 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) fbpC gene Proteins 0.000 claims 2
- 230000000890 antigenic effect Effects 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 102000034356 gene-regulatory proteins Human genes 0.000 claims 2
- 108091006104 gene-regulatory proteins Proteins 0.000 claims 2
- 230000028993 immune response Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 208000027531 mycobacterial infectious disease Diseases 0.000 claims 2
- 238000006384 oligomerization reaction Methods 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 230000037452 priming Effects 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 201000008827 tuberculosis Diseases 0.000 claims 2
- 229960005486 vaccine Drugs 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241001217856 Chimpanzee adenovirus Species 0.000 claims 1
- 241000598171 Human adenovirus sp. Species 0.000 claims 1
- 241001183012 Modified Vaccinia Ankara virus Species 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 241000990167 unclassified Simian adenoviruses Species 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0918154.6A GB0918154D0 (en) | 2009-10-16 | 2009-10-16 | Mycobacterial vaccines |
| GB0918154.6 | 2009-10-16 | ||
| PCT/GB2010/051741 WO2011045612A1 (en) | 2009-10-16 | 2010-10-15 | Mycobacterial vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013507907A JP2013507907A (ja) | 2013-03-07 |
| JP2013507907A5 true JP2013507907A5 (enExample) | 2013-11-28 |
Family
ID=41462453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533696A Pending JP2013507907A (ja) | 2009-10-16 | 2010-10-15 | マイコバクテリアワクチン |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9181311B2 (enExample) |
| EP (1) | EP2488549B1 (enExample) |
| JP (1) | JP2013507907A (enExample) |
| KR (1) | KR20120083899A (enExample) |
| CN (1) | CN102666575B (enExample) |
| AU (1) | AU2010308120B2 (enExample) |
| BR (1) | BR112012008790A2 (enExample) |
| CA (1) | CA2776001A1 (enExample) |
| EA (1) | EA201270517A1 (enExample) |
| GB (1) | GB0918154D0 (enExample) |
| NZ (1) | NZ599259A (enExample) |
| PH (1) | PH12012500849A1 (enExample) |
| WO (1) | WO2011045612A1 (enExample) |
| ZA (1) | ZA201202363B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201006405D0 (en) * | 2010-04-16 | 2010-06-02 | Isis Innovation | Poxvirus expression system |
| EP2812704A4 (en) * | 2012-02-07 | 2016-03-23 | Intuitive Biosciences Inc | MYCOBACTERIUM STUBERCULOSIS-SPECIFIC PEPTIDES FOR DETECTING INFECTION OR IMMUNIZATION OF NON-MUSCLE PRIMATES |
| US10357555B2 (en) * | 2012-07-10 | 2019-07-23 | Transgene Sa | Mycobacterial antigen vaccine |
| WO2014090905A1 (en) | 2012-12-11 | 2014-06-19 | Imaxio | Modified coiled coil type proteins having improved properties |
| JP2016520534A (ja) * | 2013-03-18 | 2016-07-14 | イマクシオＩｍａｘｉｏ | インフルエンザ核タンパク質ワクチン |
| CN103290053A (zh) * | 2013-05-17 | 2013-09-11 | 中国人民解放军第四军医大学 | 唾液腺导管细胞特异性启动子的腺病毒载体及其构建方法 |
| EP3013364B1 (en) | 2013-06-25 | 2022-08-03 | International AIDS Vaccine Initiative, Inc. | Tuberculosis compositions and methods of using the same |
| TWI654200B (zh) | 2013-08-30 | 2019-03-21 | 環球免疫公司 | 治療或預防結核病的組合物及方法 |
| JP2017504329A (ja) * | 2014-01-16 | 2017-02-09 | キャリスタ， インコーポレイテッド | アミノ酸の増強された産生のための微生物および関連する方法 |
| CN104805063A (zh) * | 2014-01-24 | 2015-07-29 | 中国人民解放军第三〇九医院 | 结核分枝杆菌潜伏感染相关蛋白及其制备和应用 |
| WO2015157561A1 (en) * | 2014-04-09 | 2015-10-15 | La Jolla Institute For Allergy And Immunology | Specific and unique t cell responses and molecular signatures for treatment and diagnosis of mycobacterium tuberculosis |
| US10067147B2 (en) * | 2014-08-29 | 2018-09-04 | Centre National De La Recherche Scientifique (C.N.R.S.) | Compositions useful in the diagnostic of latently infected Mycobacterium tuberculosis |
| EP3273990A4 (en) | 2015-03-24 | 2018-11-14 | Fred Hutchinson Cancer Research Center | Engineered and multimerized human immunodeficiency virus envelope glycoproteins and uses thereof |
| CN106237317A (zh) * | 2015-06-15 | 2016-12-21 | 复旦大学 | 由结核分枝杆菌抗原组成的结核疫苗 |
| GB201513176D0 (en) * | 2015-07-27 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| WO2017218867A1 (en) | 2016-06-16 | 2017-12-21 | Aeras | Tuberculosis compositions and methods of treating or preventing tuberculosis |
| CN108239660B (zh) * | 2016-12-26 | 2021-08-10 | 上海生物制品研究所有限责任公司 | 一种重组结核病疫苗，其制备方法及应用 |
| CA3062591A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
| WO2019144139A1 (en) * | 2018-01-22 | 2019-07-25 | Oregon State University | Immunogenic compositions comprising mycobacterium bovis surface proteins and uses thereof |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| CN110240637A (zh) * | 2019-06-04 | 2019-09-17 | 华中农业大学 | 牛分枝杆菌免疫相关的分子伴侣蛋白GroEL2及其编码基因与应用 |
| KR102193304B1 (ko) * | 2019-10-24 | 2020-12-22 | 충남대학교산학협력단 | Rv2299c-ESAT6-HspX-RipA 융합단백질의 BCG 백신 booster용 조성물 |
| CN110724182B (zh) * | 2019-11-15 | 2022-04-08 | 上海交通大学 | 提高菌阴结核感染检测敏感性的标志物组合及应用 |
| WO2021119545A1 (en) * | 2019-12-11 | 2021-06-17 | Gritstone Bio, Inc. | Durable vaccination |
| CA3187258A1 (en) | 2020-08-06 | 2022-02-10 | Karin Jooss | Multiepitope vaccine cassettes |
| CN112979825A (zh) * | 2021-02-04 | 2021-06-18 | 兰州大学 | 结核分枝杆菌融合蛋白lt29构建及其表达纯化方法和应用 |
| CN113999865B (zh) * | 2021-10-09 | 2023-06-16 | 安徽理工大学 | 结核分枝杆菌融合蛋白ar2及其构建与表达纯化方法和应用 |
| CN115920003B (zh) * | 2022-08-31 | 2024-11-29 | 中国医学科学院病原生物学研究所 | 脂蛋白LprG及其基因作为抗结核分枝杆菌药物靶点的应用 |
| CN116041543B (zh) * | 2022-12-07 | 2023-12-26 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌多抗原融合蛋白及其编码基因和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0465633A1 (en) * | 1990-01-26 | 1992-01-15 | Biogen, Inc. | C4 binding protein fusion proteins |
| CN1284854C (zh) * | 2003-03-06 | 2006-11-15 | 钟森 | 用于预防结核病和免疫治疗的嵌合型dna疫苗 |
| CN1867588A (zh) | 2003-08-12 | 2006-11-22 | 阿维迪斯公司 | 包含c4bp核心蛋白质和单体抗原的产品及其用途 |
| PT1957528E (pt) * | 2005-11-30 | 2013-01-09 | Univ Copenhagen | Uma vacina de nucleótido |
| EP1795540A1 (en) * | 2005-11-30 | 2007-06-13 | Imaxio | Multimeric complexes of antigens and an adjuvant |
| GB0706912D0 (en) * | 2007-04-10 | 2007-05-16 | Isis Innovation | Novel viral vaccines |
| CN101428143B (zh) * | 2008-12-09 | 2011-05-11 | 武汉大学 | 携带结核基因的减毒细菌载体结核疫苗及制备方法和应用 |
-
2009
- 2009-10-16 GB GBGB0918154.6A patent/GB0918154D0/en not_active Ceased
-
2010
- 2010-10-15 CA CA2776001A patent/CA2776001A1/en not_active Abandoned
- 2010-10-15 EP EP10766107.6A patent/EP2488549B1/en not_active Not-in-force
- 2010-10-15 WO PCT/GB2010/051741 patent/WO2011045612A1/en not_active Ceased
- 2010-10-15 PH PH1/2012/500849A patent/PH12012500849A1/en unknown
- 2010-10-15 EA EA201270517A patent/EA201270517A1/ru unknown
- 2010-10-15 JP JP2012533696A patent/JP2013507907A/ja active Pending
- 2010-10-15 CN CN201080057441.5A patent/CN102666575B/zh not_active Expired - Fee Related
- 2010-10-15 KR KR1020127011578A patent/KR20120083899A/ko not_active Withdrawn
- 2010-10-15 NZ NZ599259A patent/NZ599259A/en not_active IP Right Cessation
- 2010-10-15 BR BR112012008790A patent/BR112012008790A2/pt not_active IP Right Cessation
- 2010-10-15 AU AU2010308120A patent/AU2010308120B2/en not_active Ceased
- 2010-10-15 US US13/501,756 patent/US9181311B2/en not_active Expired - Fee Related
-
2012
- 2012-04-02 ZA ZA2012/02363A patent/ZA201202363B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013507907A5 (enExample) | ||
| JP2014534202A5 (enExample) | ||
| JP2008529558A5 (enExample) | ||
| JP2010500399A5 (enExample) | ||
| JP2019526580A5 (enExample) | ||
| JP2015533841A5 (enExample) | ||
| JP2017122120A5 (enExample) | ||
| JP2015524794A5 (enExample) | ||
| CN111533812B (zh) | 针对sars-cov-2病毒的dna疫苗及其用途 | |
| JP2012524733A5 (enExample) | ||
| JP2010516290A5 (enExample) | ||
| JP2019506175A5 (enExample) | ||
| RU2014144133A (ru) | Простатоассоциированные антигены и иммунотерапевтические схемы на основе вакцин | |
| JP2008539187A5 (enExample) | ||
| JP2012515557A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| JP2009544333A5 (enExample) | ||
| JP2017505605A5 (enExample) | ||
| CN111655281A (zh) | 用于结核病的含环二核苷酸佐剂的疫苗的鼻内递送 | |
| JP2018528237A5 (enExample) | ||
| JP2016106117A5 (enExample) | ||
| JP2019534884A5 (enExample) | ||
| JP7146926B2 (ja) | Ｃｄ４ヘルパーｔ細胞エピトープの融合ペプチドおよびそのワクチン | |
| JP2010532656A5 (enExample) |